Organigram Holdings Stock Current Valuation
| OGI Stock | USD 1.52 0.01 0.66% |
Valuation analysis of OrganiGram Holdings helps investors to measure OrganiGram Holdings' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of now, OrganiGram Holdings' Enterprise Value Over EBITDA is increasing as compared to previous years. The OrganiGram Holdings' current Enterprise Value Multiple is estimated to increase to 31.81, while Enterprise Value is projected to decrease to under 278.7 M. Fundamental drivers impacting OrganiGram Holdings' valuation include:
Price Book 0.7799 | Enterprise Value 109.4 M | Enterprise Value Ebitda 9.2697 | Price Sales 1.119 | Forward PE 28.9855 |
Undervalued
Today
Please note that OrganiGram Holdings' price fluctuation is moderately volatile at this time. Calculation of the real value of OrganiGram Holdings is based on 3 months time horizon. Increasing OrganiGram Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since OrganiGram Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of OrganiGram Stock. However, OrganiGram Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.52 | Real 3.29 | Target 8.8 | Hype 1.53 | Naive 1.53 |
The intrinsic value of OrganiGram Holdings' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence OrganiGram Holdings' stock price.
Estimating the potential upside or downside of OrganiGram Holdings helps investors to forecast how OrganiGram stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OrganiGram Holdings more accurately as focusing exclusively on OrganiGram Holdings' fundamentals will not take into account other important factors: OrganiGram Holdings Company Current Valuation Analysis
OrganiGram Holdings' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current OrganiGram Holdings Current Valuation | 109.39 M |
Most of OrganiGram Holdings' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OrganiGram Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
OrganiGram Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for OrganiGram Holdings is extremely important. It helps to project a fair market value of OrganiGram Stock properly, considering its historical fundamentals such as Current Valuation. Since OrganiGram Holdings' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of OrganiGram Holdings' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of OrganiGram Holdings' interrelated accounts and indicators.
Click cells to compare fundamentals
OrganiGram Current Valuation Historical Pattern
Today, most investors in OrganiGram Holdings Stock are looking for potential investment opportunities by analyzing not only static indicators but also various OrganiGram Holdings' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of OrganiGram Holdings current valuation as a starting point in their analysis.
OrganiGram Holdings Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, OrganiGram Holdings has a Current Valuation of 109.39 M. This is 99.24% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.34% higher than that of the company.
OrganiGram Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OrganiGram Holdings' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OrganiGram Holdings could also be used in its relative valuation, which is a method of valuing OrganiGram Holdings by comparing valuation metrics of similar companies.OrganiGram Holdings is currently under evaluation in current valuation category among its peers.
OrganiGram Holdings Current Valuation Drivers
We derive many important indicators used in calculating different scores of OrganiGram Holdings from analyzing OrganiGram Holdings' financial statements. These drivers represent accounts that assess OrganiGram Holdings' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of OrganiGram Holdings' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 792.0M | 286.6M | 865.7M | 438.7M | 394.8M | 278.1M | |
| Enterprise Value | 794.0M | 365.7M | 815.3M | 373.5M | 336.2M | 278.7M |
OrganiGram Fundamentals
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.0556 | ||||
| Profit Margin | (1.54) % | ||||
| Operating Margin | (0.12) % | ||||
| Current Valuation | 109.39 M | ||||
| Shares Outstanding | 108.57 M | ||||
| Shares Owned By Insiders | 31.32 % | ||||
| Shares Owned By Institutions | 9.71 % | ||||
| Number Of Shares Shorted | 2.29 M | ||||
| Price To Earning | (79.96) X | ||||
| Price To Book | 0.78 X | ||||
| Price To Sales | 1.12 X | ||||
| Revenue | 149.21 M | ||||
| Gross Profit | 35.07 M | ||||
| EBITDA | (25.37 M) | ||||
| Net Income | (229.48 M) | ||||
| Cash And Equivalents | 127.36 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 3.71 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 4.17 X | ||||
| Book Value Per Share | 2.85 X | ||||
| Cash Flow From Operations | (35.8 M) | ||||
| Short Ratio | 6.16 X | ||||
| Earnings Per Share | (1.80) X | ||||
| Target Price | 8.8 | ||||
| Number Of Employees | 914 | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 166.96 M | ||||
| Total Asset | 298.45 M | ||||
| Retained Earnings | (538.53 M) | ||||
| Working Capital | 166.34 M | ||||
| Current Asset | 204.52 M | ||||
| Current Liabilities | 54.43 M | ||||
| Net Asset | 298.45 M |
About OrganiGram Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OrganiGram Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OrganiGram Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OrganiGram Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock:Check out OrganiGram Holdings Piotroski F Score and OrganiGram Holdings Altman Z Score analysis. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.80) | Revenue Per Share 1.835 | Quarterly Revenue Growth (0.14) | Return On Assets (0.06) | Return On Equity (0.55) |
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.